The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partner Company Announces IP License Agreement

27 Nov 2008 07:00

RNS Number : 0205J
Amphion Innovations PLC
27 November 2008
 



Amphion Innovations plc Partner Company, DataTern, Signs  

Third IP License Agreement

London and New York, 27 November 2008 – Amphion Innovations plc (LSE: AMP) (“Amphion”), today announces that DataTern, Inc., has signed a non-exclusive license for its key ObjectSpark™ database patents with one of the top ten commercial banks in the world. This is the third deal since DataTern commenced licensing of this product in June 2008. The terms of the license agreement are in line with management’s expectations about the value and breadth of this technology.

Joseph Flicek, DataTern's Chief Executive Officer, said, "Following the license agreements with RedHat and VISA, this third license, signed with another leading financial institution, reinforces the strength of DataTern's technology licensing programme. We are currently in active discussions with another ten major corporations and we are looking forward to a further rollout of our licensing programme in the coming months."

DataTern, Inc., wholly owned by Amphion Innovations plc, was established in order to commercialize selected intellectual property opportunities in partnership with Amphion's Partner Companies.

Richard Morgan, Chief Executive Officer of Amphion, said, "This licensing agreement is another step forward for both DataTern and Amphion. We continue to believe that DataTern's activities will create significant added value for Amphion's shareholders as the ObjectSpark™ technologies have utility in many industries. Intellectual property is core to Amphion's proven company building process. Amphion's Partner Companies currently own or control over 150 separately identified pieces of intellectual property, a number which is growing rapidly each year. Amphion continues to seek value creation in the worldwide intellectual property industry for its Partner Companies' growing intellectual property portfolios. "

For further information please contact

Amphion Innovations Charlie Morgan +1 212 210 6224

Cardew GroupTim Robertson/ Jamie Milton/ Matthew Law +44 20 7930 0777

Charles Stanley (Nominated Adviser) Mark Taylor/ Freddy Crossley +44 20 7149 6000

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 10 Partner Companies, developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

On the web: www.amphionplc.com 

About DataTern, Inc.

DataTern owns and develops critical technology that provides next generation software solutions for our customers. DataTern's patented product offering include ObjectSpark® Technologies, which allow customers to develop their own customized data services layers, making the company's offerings valuable to most industries, including automotive, banking, chemical, communications, financial, government, healthcare, insurance, pharmaceutical, trading, and many others.

Non-exclusive licenses for DataTern's technologies and patents are available on reasonable and non-discriminatory terms. For licensing terms, please contact info@datatern.com .

On the web: www.datatern.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRQQLFLVFBXFBE
Date   Source Headline
8th Jun 20067:01 amRNSAppointment
6th Jun 20067:01 amRNSRe Agreement
5th Jun 20063:16 pmRNSThe Shafallah Center
2nd Jun 20065:01 pmRNSDr David Evans
1st Jun 20067:00 amRNSAnnual Report and Accounts
23rd May 20067:00 amRNSDirector/PDMR Shareholding
22nd May 20061:41 pmRNSDirector/PDMR Shareholding
19th May 20065:12 pmRNSDirector Share Transaction
15th Mar 20069:25 amRNSCompletion of a Financing
8th Mar 20067:04 amRNSFinal Results
2nd Mar 20069:12 amRNSMotif BioSciences
27th Feb 20064:56 pmRNSNotice of Results
23rd Feb 20067:02 amRNSRe: WellGen Financing
3rd Jan 20067:01 amRNSAdditional Investments
5th Dec 200512:48 pmRNSDirector Shareholding
10th Oct 20057:00 amRNSAcquires a stake
21st Sep 20057:00 amRNSStake in Spin-Out Company
30th Aug 20057:00 amRNSAmphion Invests in WellGen
25th Aug 20054:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.